The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.
 
Wendy M Swetzig
No Relationships to Disclose
 
John Robert Lurain
No Relationships to Disclose
 
Emily Berry
No Relationships to Disclose
 
Mario Javier Pineda
Research Funding - Merck Sharp & Dohme (Inst)
 
Shohreh Shahabi
Research Funding - Abbvie (Inst)
 
LaToya Perry
No Relationships to Disclose
 
Nikki Lynn Neubauer
No Relationships to Disclose
 
Wilberto Nieves-Neira
Travel, Accommodations, Expenses - Agenus
 
Julian C. Schink
Employment - Applied Medical (I); Cancer Treament Centers of America
 
Alissa Schiller
Travel, Accommodations, Expenses - Medtronic
 
Karen Novak
No Relationships to Disclose
 
Nancy Jean Anderson
No Relationships to Disclose
 
Kirsten Bell Burdett
Employment - QuintilesIMS
 
Anna Everett Strohl
No Relationships to Disclose
 
Masha Kocherginsky
Patents, Royalties, Other Intellectual Property - Royalties - co-inventor on Patent 9149485, "Methods and compositions related to glucocorticoid receptor antagonists and breast cancer".
 
Daniela Matei
Honoraria - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Roche/Genentech
Research Funding - Merck; Merck
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche